Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |